Insider Selling: Aflac (NYSE:AFL) Director Sells $202,831.80 in Stock

Posted by George Bondi on May 21st, 2026

Aflac Incorporated (NYSE:AFL – Get Free Report) Director Thomas Kenny sold 1,740 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $116.57, for a total transaction of $202,831.80. Following the completion of the transaction, the director directly owned 13,219 shares in the company, valued at $1,540,938.83. This trade represents a 11.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Aflac Trading Down 1.0%

AFL opened at $117.28 on Thursday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.11 and a quick ratio of 0.11. The company’s 50 day simple moving average is $112.17 and its two-hundred day simple moving average is $111.53. Aflac Incorporated has a 1-year low of $96.95 and a 1-year high of $119.81. The firm has a market capitalization of $59.69 billion, a price-to-earnings ratio of 13.31, a price-to-earnings-growth ratio of 2.06 and a beta of 0.62.

Aflac (NYSE:AFL – Get Free Report) last released its earnings results on Wednesday, April 29th. The financial services provider reported $1.75 earnings per share for the quarter, missing analysts’ consensus estimates of $1.80 by ($0.05). Aflac had a return on equity of 13.88% and a net margin of 25.60%.The business had revenue of $4.24 billion during the quarter, compared to analysts’ expectations of $4.20 billion. During the same period last year, the business earned $1.66 earnings per share. The company’s revenue for the quarter was up 27.9% compared to the same quarter last year. Analysts expect that Aflac Incorporated will post 7.12 EPS for the current fiscal year.

Aflac Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Wednesday, May 20th will be issued a dividend of $0.61 per share. The ex-dividend date is Wednesday, May 20th. This represents a $2.44 dividend on an annualized basis and a dividend yield of 2.1%. Aflac’s dividend payout ratio (DPR) is currently 27.70%.

Institutional Trading of Aflac

Institutional investors have recently added to or reduced their stakes in the stock. Whipplewood Advisors LLC acquired a new stake in Aflac in the 1st quarter valued at approximately $25,000. Quarry LP acquired a new stake in Aflac in the 4th quarter valued at approximately $25,000. Nalls Sherbakoff Group LLC acquired a new stake in Aflac in the 4th quarter valued at approximately $29,000. Evergreen Advisors LLC acquired a new stake in Aflac in the 1st quarter valued at approximately $29,000. Finally, Navalign LLC acquired a new stake in Aflac in the 4th quarter valued at approximately $32,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac News Roundup

Here are the key news stories impacting Aflac this week:

Positive Sentiment: Zacks said the accident and health insurance industry remains attractive, citing benefits from rising underwriting exposure and faster digitalization, which is supportive for Aflac and peers. Article: Zacks Industry Outlook Highlights Aflac, Unum, Globe Life, Trupanion and Employers
Positive Sentiment: The company’s quarterly dividend of $0.61 per share reinforces its appeal to income investors and may help support the stock.
Neutral Sentiment: Aflac’s latest earnings call highlighted strength in Japan, suggesting underlying business momentum even though the most recent EPS report missed expectations. Article: Aflac Earnings Call Highlights Japan Surge and Strength
Negative Sentiment: Insider selling has weighed on sentiment, including a recent $4.9 million sale by insiders and additional share sales by major shareholder Post Holdings Co. Ltd. Japan. Article: Aflac Insiders Sell US$4.9m Of Stock, Possibly Signalling Caution
Negative Sentiment: Director Thomas Kenny also sold shares, adding to concerns that insiders may be taking profits after the stock’s recent strength. Article: Aflac (NYSE:AFL) Director Sells $202,831.80 in Stock
Negative Sentiment: Investors may also stay cautious because Aflac’s last reported EPS missed analyst estimates, even though revenue came in ahead of expectations.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on AFL. Evercore upgraded shares of Aflac from a “strong sell” rating to a “strong-buy” rating in a report on Thursday, April 9th. Mizuho set a $104.00 price target on shares of Aflac in a report on Monday, May 4th. Barclays set a $99.00 price target on shares of Aflac and gave the stock an “underweight” rating in a report on Thursday, April 30th. Keefe, Bruyette & Woods raised their price target on shares of Aflac from $113.00 to $115.00 and gave the stock a “market perform” rating in a report on Friday, April 10th. Finally, Wells Fargo & Company cut their price target on shares of Aflac from $116.00 to $111.00 and set an “equal weight” rating for the company in a report on Tuesday, May 5th. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $111.36.

Read Our Latest Stock Report on Aflac

About Aflac

(Get Free Report)

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.